Market Analysis and Insights:
The research report studies the Therapeutic Drug Monitoring market using different methodologies and analyses to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Due to the COVID-19 pandemic, The global Therapeutic Drug Monitoring market size is projected to reach US$ 3296 million by 2028, from US$ 1804 million in 2021, at a CAGR of 8.81% during 2022-2028.
Scope and Segment:
The global Therapeutic Drug Monitoring market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Drug Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
By Company
- Roche
- Danaher
- Abbott
- Thermo Fisher Scientific
- Siemens Healthineers
- Bio-Rad Laboratories
- BioMerieux
- Buhlmann Laboratories
- Randox Laboratories
- Sekisui Medical
Segment by Type
- Blood Test
- Urine Test
- Saliva Test
Segment by Application
- Hospital Labs
- Independent Clinical Laboratories
- Others
By Region
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
TABLE OF CONTENTS
1 MARKET OVERVIEW OF THERAPEUTIC DRUG MONITORING
- 1.1 Therapeutic Drug Monitoring Market Overview
- 1.1.1 Therapeutic Drug Monitoring Product Scope
- 1.1.2 Therapeutic Drug Monitoring Market Status and Outlook
- 1.2 Global Therapeutic Drug Monitoring Market Size Overview by Region 2017 VS 2022 VS 2028
- 1.3 Global Therapeutic Drug Monitoring Market Size by Region (2017-2028)
- 1.4 Global Therapeutic Drug Monitoring Historic Market Size by Region (2017-2022)
- 1.5 Global Therapeutic Drug Monitoring Market Size Forecast by Region (2023-2028)
- 1.6 Key Regions Therapeutic Drug Monitoring Market Size (2017-2028)
- 1.6.1 North America Therapeutic Drug Monitoring Market Size (2017-2028)
- 1.6.2 Europe Therapeutic Drug Monitoring Market Size (2017-2028)
- 1.6.3 Asia-Pacific Therapeutic Drug Monitoring Market Size (2017-2028)
- 1.6.4 South America Therapeutic Drug Monitoring Market Size (2017-2028)
- 1.6.5 Middle East & Africa Therapeutic Drug Monitoring Market Size (2017-2028)
- 1.7 Therapeutic Drug Monitoring Revenue by Drugs Class 2017-2022
- 1.8 Times TDM Test of Drugs Every Year
2 THERAPEUTIC DRUG MONITORING MARKET OVERVIEW BY TYPE
- 2.1 Global Therapeutic Drug Monitoring Market Size by Type: 2017 VS 2022 VS 2028
- 2.2 Global Therapeutic Drug Monitoring Historic Market Size by Type (2017-2022)
- 2.3 Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2023-2028)
- 2.4 Blood Test
- 2.5 Urine Test
- 2.6 Saliva Test
3 THERAPEUTIC DRUG MONITORING MARKET OVERVIEW BY APPLICATION
- 3.1 Global Therapeutic Drug Monitoring Market Size by Application: 2017 VS 2022 VS 2028
- 3.2 Global Therapeutic Drug Monitoring Historic Market Size by Application (2017-2022)
- 3.3 Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2023-2028)
- 3.4 Hospital Labs
- 3.5 Independent Clinical Laboratories
4 THERAPEUTIC DRUG MONITORING COMPETITION ANALYSIS BY PLAYERS
- 4.1 Global Therapeutic Drug Monitoring Market Size by Players (2020-2022)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Drug Monitoring as of 2021)
- 4.3 Founded Date of Key Therapeutic Drug Monitoring Players
- 4.4 Global Top Players Therapeutic Drug Monitoring Headquarters and Area Served
- 4.5 Competitive Status
- 4.5.1 Therapeutic Drug Monitoring Market Concentration Rate
- 4.5.2 Mergers & Acquisitions, Expansion Plans
- 4.6 Big ICL in US, Europe, Japan and China
5 COMPANY (TOP PLAYERS) PROFILES AND KEY DATA
- 5.1 Roche
- 5.1.1 Roche Profile
- 5.1.2 Roche Main Business
- 5.1.3 Roche Therapeutic Drug Monitoring Products, Services and Solutions
- 5.1.4 Roche Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.1.5 Roche Recent Developments
- 5.2 Danaher
- 5.2.1 Danaher Profile
- 5.2.2 Danaher Main Business
- 5.2.3 Danaher Therapeutic Drug Monitoring Products, Services and Solutions
- 5.2.4 Danaher Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.2.5 Danaher Recent Developments
- 5.3 Abbott
- 5.3.1 Abbott Profile
- 5.3.2 Abbott Main Business
- 5.3.3 Abbott Therapeutic Drug Monitoring Products, Services and Solutions
- 5.3.4 Abbott Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.3.5 Abbott Recent Developments
- 5.4 Thermo Fisher Scientific
- 5.4.1 Thermo Fisher Scientific Profile
- 5.4.2 Thermo Fisher Scientific Main Business
- 5.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Products, Services and Solutions
- 5.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.4.5 Thermo Fisher Scientific Recent Developments
- 5.5 Siemens Healthineers
- 5.5.1 Siemens Healthineers Profile
- 5.5.2 Siemens Healthineers Main Business
- 5.5.3 Siemens Healthineers Therapeutic Drug Monitoring Products, Services and Solutions
- 5.5.4 Siemens Healthineers Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.5.5 Siemens Healthineers Recent Developments
- 5.6 Bio-Rad Laboratories
- 5.6.1 Bio-Rad Laboratories Profile
- 5.6.2 Bio-Rad Laboratories Main Business
- 5.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Products, Services and Solutions
- 5.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.7 BioMerieux
- 5.7.1 BioMerieux Profile
- 5.7.2 BioMerieux Main Business
- 5.7.3 BioMerieux Therapeutic Drug Monitoring Products, Services and Solutions
- 5.7.4 BioMerieux Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.8 Buhlmann Laboratories
- 5.8.1 Buhlmann Laboratories Profile
- 5.8.2 Buhlmann Laboratories Main Business
- 5.8.3 Buhlmann Laboratories Therapeutic Drug Monitoring Products, Services and Solutions
- 5.8.4 Buhlmann Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.9 Randox Laboratories
- 5.9.1 Randox Laboratories Profile
- 5.9.2 Randox Laboratories Main Business
- 5.9.3 Randox Laboratories Therapeutic Drug Monitoring Products, Services and Solutions
- 5.9.4 Randox Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.10 Sekisui Medical
- 5.10.1 Sekisui Medical Profile
- 5.10.2 Sekisui Medical Main Business
- 5.10.3 Sekisui Medical Therapeutic Drug Monitoring Products, Services and Solutions
- 5.10.4 Sekisui Medical Therapeutic Drug Monitoring Revenue (US$ Million) & (2020-2022)
- 5.10.5 Sekisui Medical Recent Developments
6 NORTH AMERICA
- 6.1 North America Therapeutic Drug Monitoring Market Size by Country (2017-2028)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 EUROPE
- 7.1 Europe Therapeutic Drug Monitoring Market Size by Country (2017-2028)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Rest of Europe
8 ASIA-PACIFIC
- 8.1 Asia-Pacific Therapeutic Drug Monitoring Market Size by Region (2017-2028)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 SOUTH AMERICA
- 9.1 South America Therapeutic Drug Monitoring Market Size by Country (2017-2028)
- 9.2 Brazil
- 9.3 Rest of South America
10 MIDDLE EAST & AFRICA
- 10.1 Middle East & Africa Therapeutic Drug Monitoring Market Size by Country
- 10.2 Middle East
- 10.3 Africa
11 THERAPEUTIC DRUG MONITORING MARKET DYNAMICS
- 11.1 Therapeutic Drug Monitoring Industry Trends
- 11.2 Therapeutic Drug Monitoring Market Drivers
- 11.3 Therapeutic Drug Monitoring Market Challenges
- 11.4 Therapeutic Drug Monitoring Market Restraints
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 METHODOLOGY AND DATA SOURCE
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
- 13.4 Disclaimer